Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2014 3
2015 4
2016 4
2017 11
2018 13
2019 20
2020 17
2021 25
2022 44
2023 20
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 33354667

141 results

Results by year

Filters applied: . Clear all
Page 1
Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults.
Schulte JD, Buerki RA, Lapointe S, Molinaro AM, Zhang Y, Villanueva-Meyer JE, Perry A, Phillips JJ, Tihan T, Bollen AW, Pekmezci M, Butowski N, Oberheim Bush NA, Taylor JW, Chang SM, Theodosopoulos P, Aghi MK, Hervey-Jumper SL, Berger MS, Solomon DA, Clarke JL. Schulte JD, et al. Neurooncol Adv. 2020 Oct 22;2(1):vdaa142. doi: 10.1093/noajnl/vdaa142. eCollection 2020 Jan-Dec. Neurooncol Adv. 2020. PMID: 33354667 Free PMC article.
Pediatric Diffuse Midline Gliomas H3 K27M-Mutant and Non-Histone Mutant Midline High-Grade Gliomas in Neurofibromatosis Type 1 in Comparison With Non-Syndromic Children: A Single-Center Pilot Study.
Garibotto F, Madia F, Milanaccio C, Verrico A, Piccardo A, Tortora D, Piatelli G, Diana MC, Capra V, Garrè ML, Rossi A, Morana G. Garibotto F, et al. Front Oncol. 2020 Jun 3;10:795. doi: 10.3389/fonc.2020.00795. eCollection 2020. Front Oncol. 2020. PMID: 32582540 Free PMC article.
Transcriptomic and epigenetic profiling of 'diffuse midline gliomas, H3 K27M-mutant' discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location.
Castel D, Philippe C, Kergrohen T, Sill M, Merlevede J, Barret E, Puget S, Sainte-Rose C, Kramm CM, Jones C, Varlet P, Pfister SM, Grill J, Jones DTW, Debily MA. Castel D, et al. Acta Neuropathol Commun. 2018 Nov 5;6(1):117. doi: 10.1186/s40478-018-0614-1. Acta Neuropathol Commun. 2018. PMID: 30396367 Free PMC article.
Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location.
Karremann M, Gielen GH, Hoffmann M, Wiese M, Colditz N, Warmuth-Metz M, Bison B, Claviez A, van Vuurden DG, von Bueren AO, Gessi M, Kühnle I, Hans VH, Benesch M, Sturm D, Kortmann RD, Waha A, Pietsch T, Kramm CM. Karremann M, et al. Neuro Oncol. 2018 Jan 10;20(1):123-131. doi: 10.1093/neuonc/nox149. Neuro Oncol. 2018. PMID: 29016894 Free PMC article.
Diffusion Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3-K27M Mutation Using Apparent Diffusion Coefficient Histogram Analysis.
Aboian MS, Tong E, Solomon DA, Kline C, Gautam A, Vardapetyan A, Tamrazi B, Li Y, Jordan CD, Felton E, Weinberg B, Braunstein S, Mueller S, Cha S. Aboian MS, et al. AJNR Am J Neuroradiol. 2019 Nov;40(11):1804-1810. doi: 10.3174/ajnr.A6302. Epub 2019 Nov 6. AJNR Am J Neuroradiol. 2019. PMID: 31694820 Free PMC article.
Characteristics of H3 K27M-mutant gliomas in adults.
Meyronet D, Esteban-Mader M, Bonnet C, Joly MO, Uro-Coste E, Amiel-Benouaich A, Forest F, Rousselot-Denis C, Burel-Vandenbos F, Bourg V, Guyotat J, Fenouil T, Jouvet A, Honnorat J, Ducray F. Meyronet D, et al. Neuro Oncol. 2017 Aug 1;19(8):1127-1134. doi: 10.1093/neuonc/now274. Neuro Oncol. 2017. PMID: 28201752 Free PMC article.
141 results